Interleukin-17 and - 23 Inhibitors Associated with Direct Effects on Depressive Symptoms in Psoriasis: Results from a Register Study
DOI:
https://doi.org/10.2340/actadv.v103.7138Keywords:
Psoriasis, Depression, Biologics, Systemic InflammationAbstract
Abstract is missing (Short communication)
Downloads
References
Kleyn CE, Talbot PS, Mehta NN, Sampogna F, Bundy C, Ashcroft DM, et al. Psoriasis and mental health workshop report: exploring the links between psychosocial factors, psoriasis, neuroinflammation and cardiovascular disease risk. Acta Derm Venereol 2020; 100: adv00020.
https://doi.org/10.2340/00015555-3375 DOI: https://doi.org/10.2340/00015555-3375
Tee SI, Lim ZV, Theng CT, Chan KL, Giam YC. A prospective cross-sectional study of anxiety and depression in patients with psoriasis in Singapore. J Eur Acad Dermatol Venereol 2016; 30: 1159-1164.
https://doi.org/10.1111/jdv.13615 DOI: https://doi.org/10.1111/jdv.13615
Reich A, Mędrek K, Szepietowski JC. Interplay of itch and psyche in psoriasis: an update. Acta Derm Venereol 2016; 96: 55-57.
https://doi.org/10.2340/00015555-2433
Koo J, Marangell LB, Nakamura M, Armstrong A, Jeon C, Bhutani T, et al. Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression. J Eur Acad Dermatol Venereol 2017; 31: 1999-2009.
https://doi.org/10.1111/jdv.14460 DOI: https://doi.org/10.1111/jdv.14460
Wang X, Li Y, Wu L, Xiao S, Ji Y, Tan Y, et al. Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression. Biomed Pharmacother 2021; 137: 111065.
https://doi.org/10.1016/j.biopha.2020.111065 DOI: https://doi.org/10.1016/j.biopha.2020.111065
Zafiriou E, Daponte AI, Siokas V, Tsigalou C, Dardiotis E, Bogdanos DP. Depression and obesity in patients with psoriasis and psoriatic arthritis: Is IL-17-mediated immune dysregulation the connecting link? Front Immunol 2021; 12: 699848.
https://doi.org/10.3389/fimmu.2021.699848 DOI: https://doi.org/10.3389/fimmu.2021.699848
Svedbom A, Ståhle M. Real-world comparative effectiveness of adalimumab, etanercept and methotrexate: a Swedish register analysis. J Eur Acad Dermatol Venereol 2020; 34: 525-532.
https://doi.org/10.1111/jdv.15978 DOI: https://doi.org/10.1111/jdv.15978
Svanborg P, Asberg M. A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand 1994; 89: 21-28.
https://doi.org/10.1111/j.1600-0447.1994.tb01480.x DOI: https://doi.org/10.1111/j.1600-0447.1994.tb01480.x
Oppe M, Devlin NJ, Szende A. EQ-5D value sets: inventory, comparative review and user guide. Springer, Berlin, Germany; 2007.
Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
https://doi.org/10.1159/000250839 DOI: https://doi.org/10.1159/000250839
Reich A, Riepe C, Anastasiadou Z, Mędrek K, Augustin M, Szepietowski JC, et al. Itch assessment with visual analogue scale and numerical rating scale: determination of minimal clinically important difference in chronic itch. Acta Derm Venereol 2016; 96: 978-980.
https://doi.org/10.2340/00015555-2433 DOI: https://doi.org/10.2340/00015555-2433
Dominguez PL, Husni ME, Holt EW, Tyler S, Qureshi AA. Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res 2009; 301: 573-579.
https://doi.org/10.1007/s00403-009-0981-3 DOI: https://doi.org/10.1007/s00403-009-0981-3
Finlay AY, Khan G. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
https://doi.org/10.1111/j.1365-2230.1994.tb01167.x DOI: https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
Hengartner MP, Plöderl M. Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression. BMJ Evid Based Med 2022; 27: 69-73.
https://doi.org/10.1136/bmjebm-2020-111600 DOI: https://doi.org/10.1136/bmjebm-2020-111600
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Axel Svedbom, Mona Ståhle
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
